Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heterotopic bone formation after joint replacement.

O S Nilsson1, P E Persson

  • 1Department of Orthopaedics, Uppsala University Hospital, Sweden.

Current Opinion in Rheumatology
|May 13, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heterotopic ossification.

Acta orthopaedica Scandinavica·1998
Same author

Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time.

Acta orthopaedica Scandinavica·1998
Same author

Effects of cyclosporin A on experimental new bone formation in rats.

Clinical orthopaedics and related research·1992
Same author

Total hip arthroplasty in patients 80 years of age and older.

Clinical orthopaedics and related research·1992
Same author

Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.

Seminars in arthroplasty·1992
Same author

Experimental induction of heterotopic bone.

Clinical orthopaedics and related research·1991
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Heterotopic ossification (HO) is bone formation outside the skeleton after joint replacement surgery. Identifying high-risk patients and using NSAIDs or radiation can prevent severe HO and maintain function.

Area of Science:

  • Orthopedics
  • Radiology
  • Medical Research

Background:

  • Heterotopic ossification (HO) is common after joint replacement surgery, affecting hip, knee, shoulder, or elbow.
  • While most HO cases are asymptomatic, a significant number of patients experience decreased function due to this condition.
  • The incidence of HO, though a minority, is substantial given the high volume of joint replacement procedures.

Purpose of the Study:

  • To review the incidence and risk factors of heterotopic ossification (HO) following joint arthroplasty.
  • To evaluate preventive treatment strategies for HO after hip arthroplasty.
  • To propose a treatment protocol for identifying and managing patients at risk for severe HO.

Main Methods:

  • Literature review of studies on heterotopic ossification after joint replacement.

Related Experiment Videos

  • Analysis of risk factors associated with severe HO, including prior HO, male gender with hypertrophic osteoarthrosis, ankylosing spondylitis, and diffuse idiopathic skeletal hyperostosis.
  • Evaluation of the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) and local radiation for HO prevention.

    • Main Results:

    • Identified specific risk factors for severe HO after total hip arthroplasty, likely applicable to other joints.
    • Confirmed the effectiveness of NSAIDs and local radiation in preventing HO.
    • Highlighted potential side effects associated with preventive treatments.

    Conclusions:

    • A targeted treatment protocol is necessary to prevent severe HO in at-risk patients.
    • Recommended preventive strategies include NSAIDs for 7-10 days post-surgery or a single dose of preoperative/postoperative radiation.
    • Early identification and intervention are key to mitigating functional decline caused by HO.